Deryugina Elena I, Kiosses William B
Department of Molecular Medicine, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.
Confocal Microscopy Core Facility, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.
Cell Rep. 2017 Apr 18;19(3):601-616. doi: 10.1016/j.celrep.2017.03.064.
Intravasation, active entry of cancer cells into the circulation, is often considered to be a relatively late event in tumor development occurring after stromal invasion. Here, we provide evidence that intravasation can be initiated early during tumor development and proceed in parallel to or independent of tumor invasion into surrounding stroma. By applying direct and unbiased intravasation-scoring methods to two histologically distinct human cancer types in live-animal models, we demonstrate that intravasation takes place almost exclusively within the tumor core, involves intratumoral vasculature, and does not involve vasculotropic cancer cells invading tumor-adjacent stroma and migrating along tumor-converging blood vessels. Highlighting an additional role for EGFR in cancer, we find that EGFR is required for the development of an intravasation-sustaining intratumoral vasculature. Intratumoral localization of intravasation supports the notion that overt metastases in cancer patients could be initiated much earlier during cancer progression than appreciated within conventional clinical tumor staging systems.
癌细胞主动进入循环系统的血管内渗通常被认为是肿瘤发展过程中相对较晚出现的事件,发生在基质浸润之后。在此,我们提供证据表明,血管内渗可在肿瘤发展早期启动,并与肿瘤向周围基质的浸润同时进行或独立于该过程。通过在活体动物模型中对两种组织学上不同的人类癌症类型应用直接且无偏倚的血管内渗评分方法,我们证明血管内渗几乎仅发生在肿瘤核心内,涉及肿瘤内血管,且不涉及向血管趋化的癌细胞侵入肿瘤邻近基质并沿肿瘤汇聚的血管迁移。我们发现表皮生长因子受体(EGFR)对于维持血管内渗的肿瘤内血管的发育是必需的,这突出了EGFR在癌症中的额外作用。血管内渗在肿瘤内的定位支持了这样一种观点,即癌症患者明显的转移可能在癌症进展过程中比传统临床肿瘤分期系统所认识到的要早得多就开始了。